PAR-2 antagonists (Advinus Therapeutics)

N/A

Report date: 2025/01/26 16:33:14
NME

Base Information

Drug NamePAR-2 antagonists (Advinus Therapeutics)
Drug Alias NameSB-70
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtease-activated receptor-2 antagonists
TargetsProtease-activated receptor-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEurofins Advinus Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEurofins Advinus Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A